« Back
Home /
3BP-3940

3BP-3940

Item no.	HY-P10131-25mg
Manufacturer	MedChem Express
CASRN	2803421-14-7
Amount	25 mg
Quantity options	1 ea 10 mg 1 mg 25 mg 5 mg
Category	Peptides & Proteins Peptides
Type	Peptides
Specific against	other
Purity	99.96
Citations	[1]Greifenstein L, et al. 3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177. iScience. 2023 Nov 23;26(12):108541.
Smiles	O=C1[C@@]2([H])N(CCC2)C([C@H](CSCC3=CC(CSCCNC(CN4CCN(CCN(CCN(CC4)CC(O)=O)CC(O)=O)CC(O)=O)=O)=CC(CSC[C@H](NC([C@@H](NC([C@@H](NC([C@](NC([C@@]5([H])N1CCC5)=O)([H])[C@H](O)C)=O)CCC(N)=O)=O)CC6=CC=CC=C6)=O)C(O)=O)=C3)NC(NCCCC)=O)=O
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Shipping condition	Cool pack
Available
Manufacturer - Type	Peptides
Manufacturer - Applications	Cancer-programmed cell death
Manufacturer - Targets	FAP; Radionuclide-Drug Conjugates (RDCs)
Shipping Temperature	Blue Ice
Storage Conditions	-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Product Description	3BP-3940 is a highly potent fibroblast activation protein (FAP)-targeting peptide for theranostics. 3BP-3940 is often coupled with radionuclides for tumor diagnosis and treatment[1].
Manufacturer - Research Area	Cancer
Solubility	DMSO : 100 mg/mL (ultrasonic)
Manufacturer - Pathway	Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Isoform	RDC Peptide
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-P10131-25mg-safety-datasheet.pdf